These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 12840225

  • 1. Pathways mediating the growth-inhibitory actions of vitamin D in prostate cancer.
    Peehl DM, Krishnan AV, Feldman D.
    J Nutr; 2003 Jul; 133(7 Suppl):2461S-2469S. PubMed ID: 12840225
    [Abstract] [Full Text] [Related]

  • 2. The role of vitamin D in prostate cancer.
    Krishnan AV, Peehl DM, Feldman D.
    Recent Results Cancer Res; 2003 Jul; 164():205-21. PubMed ID: 12899524
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of prostate cancer growth by vitamin D: Regulation of target gene expression.
    Krishnan AV, Peehl DM, Feldman D.
    J Cell Biochem; 2003 Feb 01; 88(2):363-71. PubMed ID: 12520538
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The role of vitamin D in prostate cancer.
    Zhao XY, Feldman D.
    Steroids; 2001 Feb 01; 66(3-5):293-300. PubMed ID: 11179737
    [Abstract] [Full Text] [Related]

  • 6. Chemoprevention of prostate cancer by cholecalciferol (vitamin D3): 25-hydroxylase (CYP27A1) in human prostate epithelial cells.
    Tokar EJ, Webber MM.
    Clin Exp Metastasis; 2005 Feb 01; 22(3):265-73. PubMed ID: 16158254
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Molecular mechanisms mediating the anti-proliferative effects of Vitamin D in prostate cancer.
    Moreno J, Krishnan AV, Feldman D.
    J Steroid Biochem Mol Biol; 2005 Oct 01; 97(1-2):31-6. PubMed ID: 16024246
    [Abstract] [Full Text] [Related]

  • 9. Synergistic growth inhibition of prostate cancer cells by 1 alpha,25 Dihydroxyvitamin D(3) and its 19-nor-hexafluoride analogs in combination with either sodium butyrate or trichostatin A.
    Rashid SF, Moore JS, Walker E, Driver PM, Engel J, Edwards CE, Brown G, Uskokovic MR, Campbell MJ.
    Oncogene; 2001 Apr 05; 20(15):1860-72. PubMed ID: 11313934
    [Abstract] [Full Text] [Related]

  • 10. 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells.
    Barreto AM, Schwartz GG, Woodruff R, Cramer SD.
    Cancer Epidemiol Biomarkers Prev; 2000 Mar 05; 9(3):265-70. PubMed ID: 10750664
    [Abstract] [Full Text] [Related]

  • 11. 1alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell growth by androgen-dependent and androgen-independent mechanisms.
    Zhao XY, Peehl DM, Navone NM, Feldman D.
    Endocrinology; 2000 Jul 05; 141(7):2548-56. PubMed ID: 10875257
    [Abstract] [Full Text] [Related]

  • 12. Molecular pathways mediating the anti-inflammatory effects of calcitriol: implications for prostate cancer chemoprevention and treatment.
    Krishnan AV, Feldman D.
    Endocr Relat Cancer; 2010 Mar 05; 17(1):R19-38. PubMed ID: 19926709
    [Abstract] [Full Text] [Related]

  • 13. Analysis of vitamin D-regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays.
    Krishnan AV, Shinghal R, Raghavachari N, Brooks JD, Peehl DM, Feldman D.
    Prostate; 2004 May 15; 59(3):243-51. PubMed ID: 15042599
    [Abstract] [Full Text] [Related]

  • 14. Human prostate cancer cells: inhibition of proliferation by vitamin D analogs.
    Schwartz GG, Oeler TA, Uskoković MR, Bahnson RR.
    Anticancer Res; 1994 May 15; 14(3A):1077-81. PubMed ID: 8074453
    [Abstract] [Full Text] [Related]

  • 15. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
    Chen TC, Schwartz GG, Burnstein KL, Lokeshwar BL, Holick MF.
    Clin Cancer Res; 2000 Mar 15; 6(3):901-8. PubMed ID: 10741714
    [Abstract] [Full Text] [Related]

  • 16. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
    Murthy S, Agoulnik IU, Weigel NL.
    Prostate; 2005 Sep 01; 64(4):362-72. PubMed ID: 15754350
    [Abstract] [Full Text] [Related]

  • 17. Molecular activity of 1,25-dihydroxyvitamin D3 in primary cultures of human prostatic epithelial cells revealed by cDNA microarray analysis.
    Peehl DM, Shinghal R, Nonn L, Seto E, Krishnan AV, Brooks JD, Feldman D.
    J Steroid Biochem Mol Biol; 2004 Oct 01; 92(3):131-41. PubMed ID: 15555907
    [Abstract] [Full Text] [Related]

  • 18. Interaction of nuclear receptor ligands with the Vitamin D signaling pathway in prostate cancer.
    Peehl DM, Feldman D.
    J Steroid Biochem Mol Biol; 2004 Nov 01; 92(4):307-15. PubMed ID: 15663994
    [Abstract] [Full Text] [Related]

  • 19. Growth inhibition and differentiation in human prostate carcinoma cells induced by the vitamin D analog 1alpha,24-dihydroxyvitamin D2.
    Bauer JA, Thompson TA, Church DR, Ariazi EA, Wilding G.
    Prostate; 2003 May 15; 55(3):159-67. PubMed ID: 12692781
    [Abstract] [Full Text] [Related]

  • 20. Vitamin D and intervention trials in prostate cancer: from theory to therapy.
    Schwartz GG.
    Ann Epidemiol; 2009 Feb 15; 19(2):96-102. PubMed ID: 18619854
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.